Bank of America’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.26M Buy
188,437
+3,630
+2% +$80.7K ﹤0.01% 3591
2025
Q4
$4.78M Buy
184,807
+25,313
+16% +$602K ﹤0.01% 3434
2025
Q3
$4.11M Sell
159,494
-136,656
-46% -$3.36M ﹤0.01% 4199
2025
Q2
$7.08M Buy
296,150
+35,220
+13% +$888K ﹤0.01% 3549
2025
Q1
$6.48M Buy
260,930
+123,733
+90% +$2.96M ﹤0.01% 3563
2024
Q4
$2.58M Sell
137,197
-104,942
-43% -$1.84M ﹤0.01% 4223
2024
Q3
$3.64M Sell
242,139
-316,848
-57% -$5.42M ﹤0.01% 4023
2024
Q2
$16M Sell
558,987
-40,412
-7% -$1.15M ﹤0.01% 2472
2024
Q1
$17.5M Buy
599,399
+144,184
+32% +$4.43M ﹤0.01% 2421
2023
Q4
$15.4M Buy
455,215
+128,327
+39% +$3.75M ﹤0.01% 2419
2023
Q3
$10M Buy
326,888
+142,487
+77% +$5.14M ﹤0.01% 2710
2023
Q2
$7.39M Sell
184,401
-41,641
-18% -$1.72M ﹤0.01% 3015
2023
Q1
$9.22M Buy
226,042
+47,975
+27% +$1.91M ﹤0.01% 2912
2022
Q4
$6.88M Sell
178,067
-16,106
-8% -$784K ﹤0.01% 3074
2022
Q3
$10.3M Sell
194,173
-27,647
-12% -$1.54M ﹤0.01% 2585
2022
Q2
$12.9M Buy
221,820
+27,769
+14% +$1.82M ﹤0.01% 2421
2022
Q1
$14.8M Buy
194,051
+3,557
+2% +$237K ﹤0.01% 2456
2021
Q4
$11.5M Sell
190,494
-9,985
-5% -$551K ﹤0.01% 2781
2021
Q3
$11.2M Buy
200,479
+18,461
+10% +$1.06M ﹤0.01% 2726
2021
Q2
$11M Sell
182,018
-12,874
-7% -$815K ﹤0.01% 2730
2021
Q1
$13.7M Buy
194,892
+46,937
+32% +$3.35M ﹤0.01% 2406
2020
Q4
$8.85M Sell
147,955
-6,415
-4% -$376K ﹤0.01% 2599
2020
Q3
$9.28M Sell
154,370
-7,028
-4% -$408K ﹤0.01% 2354
2020
Q2
$8.47M Sell
161,398
-20,760
-11% -$868K ﹤0.01% 2362
2020
Q1
$6.11M Buy
182,158
+56,232
+45% +$2.34M ﹤0.01% 2490
2019
Q4
$5.71M Buy
125,926
+1,120
+0.9% +$47.6K ﹤0.01% 3110
2019
Q3
$4.75M Sell
124,806
-8,558
-6% -$342K ﹤0.01% 3269
2019
Q2
$5.8M Sell
133,364
-95,413
-42% -$4.05M ﹤0.01% 3084
2019
Q1
$8.71M Buy
228,777
+7,205
+3% +$281K ﹤0.01% 2628
2018
Q4
$9.53M Sell
221,572
-13,619
-6% -$636K ﹤0.01% 2351
2018
Q3
$11.6M Buy
235,191
+42,690
+22% +$1.85M ﹤0.01% 2341
2018
Q2
$6.17M Sell
192,501
-3,437
-2% -$119K ﹤0.01% 2946
2018
Q1
$6.1M Buy
195,938
+12,258
+7% +$436K ﹤0.01% 2898
2017
Q4
$8.39M Buy
183,680
+9,741
+6% +$386K ﹤0.01% 2628
2017
Q3
$6.53M Sell
173,939
-11,497
-6% -$463K ﹤0.01% 2936
2017
Q2
$8.85M Buy
185,436
+68,021
+58% +$3.16M ﹤0.01% 2490
2017
Q1
$5.35M Sell
117,415
-315,778
-73% -$13.6M ﹤0.01% 2950
2016
Q4
$14M Buy
433,193
+355,526
+458% +$11.9M ﹤0.01% 2001
2016
Q3
$2.66M Sell
77,667
-49,628
-39% -$1.94M ﹤0.01% 3412
2016
Q2
$4.29M Buy
127,295
+27,607
+28% +$1.36M ﹤0.01% 2928
2016
Q1
$5.28M Sell
99,688
-28,635
-22% -$1.67M ﹤0.01% 2734
2015
Q4
$9.85M Sell
128,323
-161,199
-56% -$9.13M ﹤0.01% 2265
2015
Q3
$11.9M Buy
289,522
+246,432
+572% +$15.1M ﹤0.01% 2062
2015
Q2
$3.05M Sell
43,090
-7,940
-16% -$625K ﹤0.01% 3063
2015
Q1
$4.53M Sell
51,030
-83,757
-62% -$8.5M ﹤0.01% 2558
2014
Q4
$11.9M Buy
134,787
+38,859
+41% +$3.68M 0.01% 1782
2014
Q3
$9.3M Buy
95,928
+22,079
+30% +$2.15M ﹤0.01% 2012
2014
Q2
$6.78M Buy
73,849
+70,403
+2,043% +$5.36M ﹤0.01% 2271
2014
Q1
$241K Sell
3,446
-17,138
-83% -$1.17M ﹤0.01% 5271
2013
Q4
$1.18M Buy
20,584
+18,949
+1,159% +$996K ﹤0.01% 3890
2013
Q3
$79K Sell
1,635
-16,500
-91% -$601K ﹤0.01% 6142
2013
Q2
$526K Buy
+18,135
New +$525K ﹤0.01% 4694

Other funds holding PCRX